134 related articles for article (PubMed ID: 31709263)
1. Epilepsy Is Associated With Dysregulation of Long Non-coding RNAs in the Peripheral Blood.
Hashemian F; Ghafouri-Fard S; Arsang-Jang S; Mirzajani S; Fallah H; Mehvari Habibabadi J; Sayad A; Taheri M
Front Mol Biosci; 2019; 6():113. PubMed ID: 31709263
[No Abstract] [Full Text] [Related]
2. Downregulation of Cancer-Associated lncRNAs in Peripheral Blood of Multiple Sclerosis Patients.
Safa A; Taheri M; Fallah H; Salmani T; Arsang-Jang S; Ghafouri-Fard S; Omrani MD
J Mol Neurosci; 2020 Oct; 70(10):1533-1540. PubMed ID: 32578033
[TBL] [Abstract][Full Text] [Related]
3. Sex-specific up-regulation of lncRNAs in peripheral blood of patients with schizophrenia.
Fallah H; Azari I; Neishabouri SM; Oskooei VK; Taheri M; Ghafouri-Fard S
Sci Rep; 2019 Sep; 9(1):12737. PubMed ID: 31484957
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of
Soghala S; Harsiny K; Momeni P; Hatami M; Kholghi Oskooei V; Hussen BM; Taheri M; Ghafouri-Fard S
Heliyon; 2022 Oct; 8(10):e11155. PubMed ID: 36299522
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling revealed up-regulation of three lncRNAs in breast cancer samples.
Mohebi M; Sattari A; Ghafouri-Fard S; Modarressi MH; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Dec; 117():104544. PubMed ID: 32976818
[TBL] [Abstract][Full Text] [Related]
6. Alteration in the expression of long non-coding RNAs in the circulation of migraineurs.
Taheri M; Eghtedarian R; Eslami S; Hussen BM; Ghafouri-Fard S; Ayatollahi SA
Acta Neurol Belg; 2024 Apr; ():. PubMed ID: 38625499
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's Disease Is Associated With Dysregulation of Circulatory Levels of lncRNAs.
Honarmand Tamizkar K; Gorji P; Gholipour M; Hussen BM; Mazdeh M; Eslami S; Taheri M; Ghafouri-Fard S
Front Immunol; 2021; 12():763323. PubMed ID: 34868009
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of lncRNAs in autoimmune neuropathies.
Gholipour M; Taheri M; Mehvari Habibabadi J; Nazer N; Sayad A; Ghafouri-Fard S
Sci Rep; 2021 Aug; 11(1):16061. PubMed ID: 34373511
[TBL] [Abstract][Full Text] [Related]
9. A Review on the Expression Pattern of Non-coding RNAs in Patients With Schizophrenia: With a Special Focus on Peripheral Blood as a Source of Expression Analysis.
Ghafouri-Fard S; Eghtedarian R; Taheri M; Beatrix Brühl A; Sadeghi-Bahmani D; Brand S
Front Psychiatry; 2021; 12():640463. PubMed ID: 34220567
[TBL] [Abstract][Full Text] [Related]
10. Expression Analysis of lncRNAs in Refractory and Non-Refractory Epileptic Patients.
Mirzajani S; Ghafouri-Fard S; Habibabadi JM; Arsang-Jang S; Omrani MD; Fesharaki SSH; Sayad A; Taheri M
J Mol Neurosci; 2020 May; 70(5):689-698. PubMed ID: 31900886
[TBL] [Abstract][Full Text] [Related]
11. Microarray Analysis of Long Non-Coding RNAs in Lung Tissues of Patients with COPD and HOXA-AS2 Promotes HPMECs Proliferation via Notch1.
Zhou AY; Zhao YY; Zhou ZJ; Duan JX; Zhu YZ; Cai S; Chen P
Int J Chron Obstruct Pulmon Dis; 2020; 15():2449-2460. PubMed ID: 33116460
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of long non-coding RNA HOXA-AS2 in non-small cell lung cancer is associated with worse survival outcome.
Li Y; Jiang H
Int J Clin Exp Pathol; 2017; 10(9):9690-9696. PubMed ID: 31966850
[TBL] [Abstract][Full Text] [Related]
13. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer.
Wang J; Su Z; Lu S; Fu W; Liu Z; Jiang X; Tai S
Clin Chim Acta; 2018 Oct; 485():229-233. PubMed ID: 29981289
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of HOXA-AS2 suppresses proliferation and induces apoptosis in colorectal cancer.
Tong G; Wu X; Cheng B; Li L; Li X; Li Z; Nong Q; Chen X; Liu Y; Wang S
Am J Transl Res; 2017; 9(10):4545-4552. PubMed ID: 29118916
[TBL] [Abstract][Full Text] [Related]
16. The lncRNA-HOXA-AS2/EZH2/LSD1 oncogene complex promotes cell proliferation in pancreatic cancer.
Lian Y; Li Z; Fan Y; Huang Q; Chen J; Liu W; Xiao C; Xu H
Am J Transl Res; 2017; 9(12):5496-5506. PubMed ID: 29312501
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
18. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.
Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z
Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.
Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T
Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer.
Ding J; Xie M; Lian Y; Zhu Y; Peng P; Wang J; Wang L; Wang K
Oncogenesis; 2017 Jan; 6(1):e288. PubMed ID: 28112720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
